Evidence map›Paper›PMID 32450309›Full record

ReviewWorld neurosurgery2020

Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the Future During the COVID-19 Pandemic.

Lekhaj C Daggubati, Daniel G Eichberg, Michael E Ivan, Simon Hanft, Alireza Mansouri, Ricardo J Komotar, Randy S D'Amico, Brad E Zacharia

Open access · greenAbstract readReview
In one paragraph

Review in World neurosurgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. How has the COVID-19 pandemic impacted clinical care and research in Neuro-Oncology?Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Oncology patients' communication experiences during COVID-19: comparing telehealth consultations to in-person visits.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  17. Article
  18. Telemedicine during and post-COVID 19: The insights of neurosurgery patients and physicians.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Lekhaj C DaggubatiDepartment of Neurosurgery, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania, USA.
Daniel G EichbergDepartment of Neurosurgery, University of Miami, Miami, Florida, USA.
Michael E IvanDepartment of Neurosurgery, University of Miami, Miami, Florida, USA; Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
Simon HanftDepartment of Neurosurgery, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Alireza MansouriDepartment of Neurosurgery, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania, USA; Penn State Cancer Institute, Hershey, Pennsylvania, USA.
Ricardo J KomotarDepartment of Neurosurgery, University of Miami, Miami, Florida, USA; Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
Randy S D'AmicoDepartment of Neurosurgery, Lenox Hill Hospital/Northwell Health, New York, New York, USA.
Brad E ZachariaDepartment of Neurosurgery, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania, USA; Penn State Cancer Institute, Hershey, Pennsylvania, USA. Electronic address: bzacharia@pennstatehealth.psu.edu.
Pennsylvania State University · USUniversity of Miami · USNorthwell Health · USRutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus 2019 (COVD-19) pandemic has drastically disrupted the delivery of neurosurgical care, especially for the already at-risk neuro-oncology population. The sudden change to clinic visits has rapidly spurned the implementation of telemedicine. A recommendation care paradigm of neuro-oncologic patients limited by telemedicine has not been reported.

methodsA summary of a multi-institution experience detailing the potential benefits, pitfalls, and the necessary considerations to outpatient care of neurosurgical oncology patients.

resultsThere are limitations and advantages to incorporating telemedicine into the outpatient care of neuro-oncology patients. Telemedicine-specific considerations for each step and stakeholder of the appointment (physician, patient, scheduling, previsit, imaging, and physical examination) are examined.

conclusionsTelemedicine, pushed to prominence during this COVID-19 pandemic, is a powerful and possibly preferential tool for the future of outpatient neuro-oncologic care.

Indexed as

BetacoronavirusAmbulatory Surgical ProceduresCoronavirus InfectionsCOVID-19ForecastingHumansMedical OncologyNeurosurgeryPandemicsPneumonia, ViralSARS-CoV-2TelemedicineBrain tumorCoronavirusCOVID-19Neuro-oncologyTelehealthTelemedicine

Identifiers

PMID32450309
PMCPMC7243783
OpenAlexW3027828606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.